Please contact us with any questions or if you'd like to explore your legal rights
Name 
Email Address 
Phone 
Message 
Diet Drugs (Fen-Phen and Redux)
The Law Firm of Motley Rice LLC Legal services for people harmed by diet drugs such as Fen-Phen and Redux Fen-Phen is a combination of Fenfluramine and Phentermine, two drugs which have been on the market since the 1970s for weight loss. Fenfluramine (Fen) is sold under the trade name of Pondimin and is made by A.H. Robbins, a wholly-owned subsidiary of American Home Products. Phentermine (Phen) is sold under a number of trade names, including Ionamin (sold by Medeva), Fastin (SmithKline Beecham), Adipex (Gate), Banobese (Seatrace), Obenix (Abana Pharmaceuticals), Oby-Cap (Richwood) and Zantryl (Ion).

The Food and Drug Administration has not approved the combination of these drugs. Therefore, a physician who prescribes a Fen-Phen regime is engaged in an off-label use of a prescription drug. While physicians are not limited in prescribing drugs to the approved FDA indications, they do take risks in prescribing for off-label uses which, at a minimum, increase their duty to inform patients.

A third drug involved in Fen-Phen cases is called Redux, which is sold by Wyeth-Ayerst Laboratories, the manufacturers of Norplant and a wholly-owned subsidiary of American Home Products. Redux is the brand name of Dexfenfluramine, a purified form of Fenfluramine.

Combinations of these drugs may induce conditions that cause regurgitation, stroke, heart attack, primary pulmonary hypertension and heart valve damage.

The Law Firm of Motley Rice LLC Legal services for people harmed by diet drugs such as Fen-Phen and Redux Motley Rice is actively involved in these cases. If you have just learned you might have pulmonary hypertension and did take Fen-Phen or Redux, please contact us with any questions or if you'd like to explore your legal rights.